Roche Holding Ltd.

Pharmaceuticals
Switzerland
Earnings Per Share Growth (%)-4.90%
Cost of Goods Sold (US$ Millions)$15,567
Current Liabilities (US$ Millions)$23,933
Total Assets (US$ Millions)$28,378
Long Term Debt$17,219
Return on Equity45.25%
Revenue (US$ Millions)$50,753
Total Company Assets$76,289
Revenue Growth (%)1.08%
Net Income (US$ Millions)$8,925
Earnings Per Share (US$)($4.90)
Total Equity (US$ Millions)$21,125
Profit Margin (%)17.58%
Debt To Equity Ratio (%)0.82%
Inventory Turnover$7,701